Home » Topics » Regulatory

Regulatory
RSS

Reboxetine + pindolol rapidly relieves symptoms of depression and other CNS disorders

Dec. 30, 1999

Injectable levocarnitine approved for use in dialysis in U.S.

Dec. 28, 1999

FDA clears Taxotere for marketing in NSCLC

Dec. 28, 1999

Celebrex approved by FDA for adjunctive therapy of FAP

Dec. 27, 1999

FDA approves depot form of Genentech's GH, efficacy of other formulations in increasing spine BMD

Dec. 27, 1999

Allergan's therapy for allergic conjunctivitis approved for U.S. marketing

Dec. 27, 1999

Organogenesis seeks FDA approval of Apligraf for diabetic foot ulcers

Dec. 23, 1999

New use for sPLA2 inhibitor claimed by Lilly: LY-315920 for IBS

Dec. 23, 1999

FDA is first agency worldwide to approve new fluoroquinolone for marketing

Dec. 22, 1999

Dexmedetomidine receives FDA marketing approval

Dec. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...